The Extracellular Matrix Protein TGFBI Induces Microtubule Stabilization and Sensitizes Ovarian Cancers to Paclitaxel
Open Access
- 6 December 2007
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 12 (6), 514-527
- https://doi.org/10.1016/j.ccr.2007.11.014
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Rb Loss Causes Cancer by Driving Mitosis MadCancer Cell, 2007
- Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanesJournal of Bone and Joint Surgery, 2006
- Epigenetic Inactivation of Betaig-h3 Gene in Human Cancer CellsCancer Research, 2006
- Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cellsMolecular Carcinogenesis, 2006
- ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinaseCell Death & Differentiation, 2006
- Beta ig-h3 promotes renal proximal tubular epithelial cell adhesion, migration and proliferation through the interaction with α3β1 integrinExperimental & Molecular Medicine, 2004
- Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cellsSurgery, 2004
- Localized Stabilization of Microtubules by Integrin- and FAK-Facilitated Rho SignalingScience, 2004
- The Transforming Growth Factor-β-inducible Matrix Protein βig-h3 Interacts with FibronectinOnline Journal of Public Health Informatics, 2002
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerThe New England Journal of Medicine, 1996